Nootropic
Souvenaid
SaveA medical food containing Fortasyn Connect — a specific combination of DHA, EPA, UMP, choline, B vitamins, and phospholipids designed to support synaptic membrane formation in early Alzheimer's disease.
Quick verdict
The LipiDiDiet trial showed slowed brain atrophy and functional decline in prodromal AD over 3 years. Not a nootropic for healthy users but one of the few nutritional interventions with decent AD trial data.
Evidence score
A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.
What the research shows
The Souvenir II trial showed improved memory in mild AD. The LipiDiDiet trial (n=311) demonstrated reduced brain atrophy and slowed clinical decline over 36 months in prodromal AD. Effects are specific to early disease stages.
Benefits
- Slowed brain atrophy in the LipiDiDiet trial
- Improved memory scores in mild AD (Souvenir II)
- Well tolerated with a good safety profile
Dosage notes
One 125 mL drink daily, providing the full Fortasyn Connect nutrient combination.
Side effects
- GI discomfort (uncommon)
- Fishy aftertaste
Who should be cautious
Designed for early Alzheimer's, not healthy cognition. Expensive. Not a substitute for medical care.
What this page cannot tell you
Benefits are specific to prodromal/early AD populations. No evidence of cognitive enhancement in healthy individuals.
Leaderboard scores
- Memory45
- Longevity30
Write a review
Sign in to write a review.